B-type natriuretic peptide: application in the community.
2008 (English)In: Congestive Heart Failure, ISSN 1527-5299, no 14, 12-16 p.Article in journal (Refereed) Published
Natriuretic peptide assessment has represented a significant advance in the management of heart failure. In a syndrome in which clinical symptoms and signs can be either nonspecific or absent, the presence of a reliable biomarker to aid diagnosis, assess prognosis, and potentially guide treatment and aid in prevention of this syndrome has represented a significant advance. The following review will outline established and potential new roles for natriuretic peptide assessment in the community
Place, publisher, year, edition, pages
2008. no 14, 12-16 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-21785DOI: 10.1111/j.1751-7133.2008.08226.xOAI: oai:DiVA.org:liu-21785DiVA: diva2:241707